These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 31163381

  • 1. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
    Weng MC, Li MH, Chung JG, Liu YC, Wu JY, Hsu FT, Wang HE.
    Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
    [Abstract] [Full Text] [Related]

  • 2. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
    Liu YC, Tsai JJ, Weng YS, Hsu FT.
    Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
    [Abstract] [Full Text] [Related]

  • 3. Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-κB-modulated tumor progression in bladder cancer in vitro and in vivo.
    Chiang CH, Chung JG, Hsu FT.
    Environ Toxicol; 2019 Jun; 34(6):679-688. PubMed ID: 30801954
    [Abstract] [Full Text] [Related]

  • 4. Lenvatinib Inhibits AKT/NF-κB Signaling and Induces Apoptosis Through Extrinsic/Intrinsic Pathways in Non-small Cell Lung Cancer.
    Liu YC, Huang BH, Chung JG, Liu WL, Hsu FT, Lin SS.
    Anticancer Res; 2021 Jan; 41(1):123-130. PubMed ID: 33419805
    [Abstract] [Full Text] [Related]

  • 5. Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice.
    Weng MC, Wang MH, Tsai JJ, Kuo YC, Liu YC, Hsu FT, Wang HE.
    Biosci Rep; 2018 Jun 29; 38(3):. PubMed ID: 29535278
    [Abstract] [Full Text] [Related]

  • 6. Lenvatinib Induces AKT/NF-κB Inactivation, Apoptosis Signal Transduction and Growth Inhibition of Non-small Cell Lung Cancer In Vivo.
    Liu YC, Hsu FT, Chung JG, Weng MC, Ting CY, Tsai CJ, Lan A, Wu JY, Lin CC, Lin SS.
    Anticancer Res; 2021 Jun 29; 41(6):2867-2874. PubMed ID: 34083277
    [Abstract] [Full Text] [Related]

  • 7. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells.
    Tsai JJ, Pan PJ, Hsu FT.
    Oncol Rep; 2017 Feb 29; 37(2):1036-1044. PubMed ID: 28000898
    [Abstract] [Full Text] [Related]

  • 8. Consumption of S-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model.
    Tang FY, Chiang EP, Pai MH.
    J Agric Food Chem; 2010 Oct 27; 58(20):11156-64. PubMed ID: 20866043
    [Abstract] [Full Text] [Related]

  • 9. Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer.
    Chen WT, Chen YK, Lin SS, Hsu FT.
    Anticancer Res; 2018 Apr 27; 38(4):2161-2167. PubMed ID: 29599335
    [Abstract] [Full Text] [Related]

  • 10. Induction of Apoptosis and Inhibition of EGFR/NF-κB Signaling Are Associated With Regorafenib-sensitized Non-small Cell Lung Cancer to Cisplatin.
    Wu JY, Weng YS, Chiou YC, Hsu FT, Chiang IT.
    In Vivo; 2021 Apr 27; 35(5):2569-2576. PubMed ID: 34410944
    [Abstract] [Full Text] [Related]

  • 11. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo.
    Zhou B, Wang D, Sun G, Mei F, Cui Y, Xu H.
    Cell Physiol Biochem; 2018 Apr 27; 46(3):999-1008. PubMed ID: 29669316
    [Abstract] [Full Text] [Related]

  • 12. Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo.
    Su CM, Weng YS, Kuan LY, Chen JH, Hsu FT.
    Int J Mol Sci; 2020 May 16; 21(10):. PubMed ID: 32429376
    [Abstract] [Full Text] [Related]

  • 13. Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo.
    Wu CH, Hsu FT, Chao TL, Lee YH, Kuo YC.
    Biomed Pharmacother; 2022 Jan 16; 145():112437. PubMed ID: 34864311
    [Abstract] [Full Text] [Related]

  • 14. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.
    Song L, Xiong H, Li J, Liao W, Wang L, Wu J, Li M.
    Clin Cancer Res; 2011 Apr 01; 17(7):1839-49. PubMed ID: 21325072
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model.
    Hsu LC, Tu HF, Hsu FT, Yueh PF, Chiang IT.
    Biomed Pharmacother; 2020 Jun 01; 126():110054. PubMed ID: 32145588
    [Abstract] [Full Text] [Related]

  • 16. Amentoflavone Induces Cell-cycle Arrest, Apoptosis, and Invasion Inhibition in Non-small Cell Lung Cancer Cells.
    Chen WT, Chen CH, Su HT, Yueh PF, Hsu FT, Chiang IT.
    Anticancer Res; 2021 Mar 01; 41(3):1357-1364. PubMed ID: 33788727
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of Akt/NF-κB-regulated inflammation and Akt/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle.
    Tang B, Tang F, Wang Z, Qi G, Liang X, Li B, Yuan S, Liu J, Yu S, He S.
    Int J Nanomedicine; 2016 Mar 01; 11():6401-6420. PubMed ID: 27942213
    [Abstract] [Full Text] [Related]

  • 18. Se-methylselenocysteine inhibits the progression of non-small cell lung cancer via ROS-mediated NF-κB signaling pathway.
    Ge L, Liu P, Tian L, Li Y, Chen L.
    Exp Cell Res; 2024 Jul 01; 440(1):114101. PubMed ID: 38815788
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q, Yue J, Zhang C, Gu X, Chen H, Xu L.
    Oncotarget; 2015 Oct 06; 6(30):29335-46. PubMed ID: 26336823
    [Abstract] [Full Text] [Related]

  • 20. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY.
    Liver Int; 2015 Apr 06; 35(4):1416-29. PubMed ID: 25066210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.